CSL Shares Fall Amid Target Price Cut by Morgans Financial

MT Newswires Live
Jul 11

CSL (ASX:CSL) shares fell 0.4% on Friday after Morgans Financials said it expects softer sales for the Seqirus and Vifor segments of the company, according to the research firm's website.

Morgan Financials sees the company as significantly undervalued, currently trading at an enterprise value to earnings before interest and taxes ratio of 18.2 times, which is over 25% below its 10-year average of 24.7 times.

The research firm noted that a conservative sum-of-the-parts valuation suggests a fair value of AU$196 billion, indicating about 35% upside from the current share price.

The market seems to be pricing the company at less than the value of just its core Behring division, applying a roughly 10% discount and attributing no value, or even negative value, to its Seqirus and Vifor businesses, the website added.

Morgans Financial has cut its price target to AU$303.70 with a buy recommendation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10